Get Live Data

Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Biopharma Cred. Share Price
  4. Biopharma Cred. Share Regulatory News
  5. STATEMENT RE COHERUS BIOSCIENCES, INC.

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.84
Bid: 0.836
Ask: 0.844
Change: -0.012 (-1.41%)
Spread: 0.008 (0.957%)
Open: 0.85
High: 0.86
Low: 0.84
Prev. Close: 0.852
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

STATEMENT RE COHERUS BIOSCIENCES, INC.

10 May 2024 15:11

RNS Number : 0397O
BioPharma Credit PLC
10 May 2024
 

BioPharma Credit PLC

10 May 2024

 

 

 

 

BIOPHARMA CREDIT PLC

 

(THE "COMPANY")

 

STATEMENT RE Coherus BIOSCIENCES, Inc.

 

Pharmakon Advisors, LP, the investment manager of the Company, notes the announcement released 9 May 2024 by Coherus Biosciences, Inc. ("Coherus") regarding entering into a combined term loan and product royalty financing agreement with Barings (the "New Financing"). The New Financing allowed Coherus to fully pay off its remaining USD$75 million senior secured term loan, of which the Company had an investment of USD$37.5 million.

 

The Company had previously announced on 10 January 2022 an investment in a senior secured loan to Coherus of up to USD$150 million in up to three tranches. The Company had previously funded US$125 million, of which USD$87.5 million was repaid as referenced in the Company's announcement on 6 February 2024. The remaining USD$37.5 million was repaid to the Company in connection with the New Financing. In connection with this final repayment, the Company received US$39.8 million in total, including USD$2.3 million of accrued interest, and prepayment and make-whole fees.

 

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 509

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUBUAUPCGCU
12345678910
Date   Source Headline
22nd May 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
13th May 202411:40 amRNSDirector/PDMR Shareholding
10th May 20243:11 pmRNSSTATEMENT RE COHERUS BIOSCIENCES, INC.
8th May 20243:52 pmRNSHolding(s) in Company
7th May 20246:15 pmRNSTransaction in Own Shares
3rd May 20246:15 pmRNSTransaction in Own Shares
2nd May 20246:15 pmRNSTransaction in Own Shares
2nd May 202412:18 pmRNSNEW INVESTMENT OF UP TO US$400 MILLION
1st May 202410:25 amRNSTotal Voting Rights
30th Apr 20246:15 pmRNSTransaction in Own Shares
29th Apr 20246:15 pmRNSTransaction in Own Shares
26th Apr 20246:15 pmRNSTransaction in Own Shares
24th Apr 20246:15 pmRNSTransaction in Own Shares
24th Apr 20247:00 amRNSNEW INVESTMENT OF UP TO US$100 MILLION
23rd Apr 20246:15 pmRNSTransaction in Own Shares
22nd Apr 20246:15 pmRNSTransaction in Own Shares
22nd Apr 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
19th Apr 20246:15 pmRNSTransaction in Own Shares
18th Apr 20246:15 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSNotice of AGM
17th Apr 20246:15 pmRNSTransaction in Own Shares
16th Apr 20246:15 pmRNSTransaction in Own Shares
15th Apr 20246:15 pmRNSTransaction in Own Shares
12th Apr 20246:15 pmRNSTransaction in Own Shares
11th Apr 20246:15 pmRNSTransaction in Own Shares
10th Apr 20246:15 pmRNSTransaction in Own Shares
9th Apr 20246:15 pmRNSTransaction in Own Shares
8th Apr 20246:15 pmRNSTransaction in Own Shares
4th Apr 20246:15 pmRNSTransaction in Own Shares
3rd Apr 20246:15 pmRNSTransaction in Own Shares
2nd Apr 20246:15 pmRNSTransaction in Own Shares
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
27th Mar 20247:01 amRNSUPDATES TO THE DISCOUNT CONTROL MECHANISM
27th Mar 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
25th Mar 202411:35 amRNSDirector/PDMR Shareholding
21st Mar 20244:05 pmRNSDividend Declaration
21st Mar 20244:00 pmRNSNet Asset Value(s)
15th Mar 20244:35 pmRNSUPDATE ON INVESTMENT
11th Mar 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
1st Mar 20243:10 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSNotice of Full Year Results
26th Feb 20246:15 pmRNSTransaction in Own Shares
20th Feb 20246:15 pmRNSTransaction in Own Shares
19th Feb 20246:15 pmRNSTransaction in Own Shares
16th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20247:00 amRNSSTATEMENT RE IMMUNOGEN, INC.
9th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20247:00 amRNSDividend Declaration
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.